€111.05
2.82% today
Xetra, Aug 12, 05:35 pm CET
ISIN
DE0006599905
Symbol
MRK
Index

Merck Stock price

€111.05
+1.20 1.09% 1M
-23.45 17.43% 6M
-28.85 20.62% YTD
-55.70 33.40% 1Y
-72.55 39.52% 3Y
-4.95 4.27% 5Y
+25.71 30.13% 10Y
+75.70 214.16% 20Y
Xetra, Closing price Tue, Aug 12 2025
+3.05 2.82%
ISIN
DE0006599905
Symbol
MRK
Index
Industry

Key metrics

Basic
Market capitalization
€47.0b
Enterprise Value
€54.8b
Net debt
€7.8b
Cash
€1.6b
Shares outstanding
434.8m
Valuation (TTM | estimate)
P/E
16.4 | 11.6
P/S
2.2 | 2.2
EV/Sales
2.6 | 2.5
EV/FCF
30.7
P/B
1.7
Dividends
DPS
€2.20
Yield 1Y | 5Y
2.0% | 1.3%
Growth 1Y | 5Y
0.0% | 11.1%
Payout 1Y | 3Y
34.4% | 32.1%
Increased
0 Years
Financials (TTM | estimate)
Revenue
€21.2b | €21.8b
EBITDA
€5.8b | €6.2b
EBIT
€3.8b | €4.6b
Net Income
€2.9b | €4.1b
Free Cash Flow
€1.8b
Growth (TTM | estimate)
Revenue
1.7% | 2.8%
EBITDA
5.8% | 26.5%
EBIT
13.8% | 5.9%
Net Income
9.0% | 46.4%
Free Cash Flow
-12.6%
Margin (TTM | estimate)
Gross
58.5%
EBITDA
27.1% | 28.7%
EBIT
18.1%
Net
13.5% | 18.7%
Free Cash Flow
8.4%
Financial Health
Equity Ratio
58.0%
Return on Equity
9.3%
ROCE
10.2%
ROIC
7.7%
Debt/Equity
0.3
More
EPS
€6.6
FCF per Share
€4.1
Short interest
-
Employees
59k
Rev per Employee
€360.0k
Show more

Create a Free Account to create an Merck alert.

Set up alerts on Stock Price, Dividend Yield, Valuation (e.g. P/E or EV/Sales) or Strategy Scores and sit back and relax.

Merck Stock Analysis

Unlock Scores for Free

Analyst Opinions

24 Analysts have issued a Merck forecast:

18x Buy
75%
3x Hold
13%
3x Sell
13%

Analyst Opinions

24 Analysts have issued a Merck forecast:

Buy
75%
Hold
13%
Sell
13%

Financial data from Merck

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
21,219 21,219
2% 2%
100%
- Direct Costs 8,804 8,804
1% 1%
41%
12,415 12,415
2% 2%
59%
- Selling and Administrative Expenses 5,948 5,948
2% 2%
28%
- Research and Development Expense 2,141 2,141
13% 13%
10%
5,759 5,759
6% 6%
27%
- Depreciation and Amortization 1,930 1,930
7% 7%
9%
EBIT (Operating Income) EBIT 3,829 3,829
14% 14%
18%
Net Profit 2,862 2,862
9% 9%
13%

In millions EUR.

Don't miss a Thing! We will send you all news about Merck directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Merck Stock News

AD HOC NEWS
6 days ago
Die Dollar-Schwäche hat dem Merck-Konzern DE0006599905 ein unerwartet schwaches zweites Quartal eingebrockt.
AD HOC NEWS
6 days ago
DARMSTADT - Die Dollar-Schwäche hat dem Merck-Konzern DE0006599905 ein unerwartet schwaches zweites Quartal eingebrockt.
AD HOC NEWS
6 days ago
Eine schwache Elektroniksparte der Merck KGaA DE0006599905 im zweiten Quartal hat am Donnerstag am Aktienmarkt für Enttäuschung gesorgt.
More Merck News

Company Profile

Merck KGaA is a science and technology company, which engages in the manufacture of pharmaceutical and chemical products. It operates through the following sectors: Healthcare, Life Science, and Performance Materials. The Healthcare sector discovers, develops, and produces prescription medicines used to treat cancer, multiple sclerosis, and infertility. The Life Science sector provides scientists with laboratory materials, technologies, and services. The Performance Materials sector offers specialty chemicals and materials for demanding applications. The firm offers pharma and biopharma manufacturing, pharmaceutical research, pharma quality control, and government and academic research services. The company was founded by Friedrich Jacob Merck in 1668 and is headquartered in Darmstadt, Germany.

Head office Germany
CEO Belén López
Employees 59,020
Founded 1995
Website www.merckgroup.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today